Teleflex (NYSE:TFX) Issues FY 2025 Earnings Guidance

Teleflex (NYSE:TFX) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 14.000-14.200 for the period, compared to the consensus EPS estimate of 14.040. The company issued revenue guidance of $3.3 billion-$3.3 billion, compared to the consensus revenue estimate of $3.3 billion.

Teleflex Trading Up 0.0%

Shares of Teleflex stock traded up $0.01 on Friday, reaching $108.52. The company had a trading volume of 567,890 shares, compared to its average volume of 741,960. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The firm has a market cap of $4.80 billion, a PE ratio of 25.52, a PEG ratio of 1.79 and a beta of 1.05. The firm’s 50 day moving average price is $126.01 and its two-hundred day moving average price is $123.27. Teleflex has a 52-week low of $102.58 and a 52-week high of $200.15.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business’s quarterly revenue was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Sell-side analysts predict that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Friday, November 14th. Teleflex’s dividend payout ratio is presently 32.00%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Royal Bank Of Canada cut their price target on Teleflex from $135.00 to $120.00 and set a “sector perform” rating for the company in a research note on Friday. Wall Street Zen downgraded shares of Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. Wells Fargo & Company cut their price target on shares of Teleflex from $131.00 to $114.00 and set an “equal weight” rating for the company in a report on Friday. Zacks Research lowered Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $137.00.

Institutional Investors Weigh In On Teleflex

Several hedge funds have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company lifted its holdings in Teleflex by 146.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 231,624 shares of the medical technology company’s stock worth $27,415,000 after purchasing an additional 137,470 shares during the last quarter. Sei Investments Co. lifted its holdings in shares of Teleflex by 11.0% during the second quarter. Sei Investments Co. now owns 113,559 shares of the medical technology company’s stock worth $13,441,000 after buying an additional 11,289 shares in the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Teleflex by 71.9% in the second quarter. Daiwa Securities Group Inc. now owns 9,342 shares of the medical technology company’s stock valued at $1,106,000 after acquiring an additional 3,907 shares in the last quarter. California Public Employees Retirement System grew its stake in shares of Teleflex by 0.5% in the second quarter. California Public Employees Retirement System now owns 78,711 shares of the medical technology company’s stock valued at $9,316,000 after acquiring an additional 391 shares in the last quarter. Finally, Cerity Partners LLC increased its position in Teleflex by 159.6% during the second quarter. Cerity Partners LLC now owns 23,126 shares of the medical technology company’s stock worth $2,737,000 after acquiring an additional 14,219 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.